1 |
Gorgoulis V, Adams PD, Alimonti A, et al. Cellular senescence: defining a path forward[J]. Cell, 2019, 179(4):813-827.
|
2 |
Durand F, Levitsky J, Cauchy F, et al. Age and liver transplantation[J]. J Hepatol, 2019, 70(4):745-758.
|
3 |
Lim WH, Clayton P, Wong G, et al. Outcomes of kidney transplantation from older living donors[J]. Transplantation, 2013, 95(1):106-113.
|
4 |
Tasaki M, Saito K, Nakagawa Y, et al. Effect of donor-recipient age difference on long-term graft survival in living kidney transplantation[J]. Int Urol Nephrol, 2014, 46(7):1441-1446.
|
5 |
Kurschat C. Kidney transplantation in old age[J]. Z Gerontol Geriatr, 2016, 49(6):488-493. (in German)
|
6 |
Braun H, Schmidt BM, Raiss M, et al. Cellular senescence limits regenerative capacity and allograft survival[J]. J Am Soc Nephrol, 2012, 23(9):1467-1473.
|
7 |
Melk A, Schmidt BM, Vongwiwatana A, et al. Increased expression of senescence-associated cell cycle inhibitor p16INK4a in deteriorating renal transplants and diseased native kidney[J]. Am J Transplant, 2005, 5(6):1375-1382.
|
8 |
Song S, Lam EW, Tchkonia T, et al. Senescent cells: emerging targets for human aging and age-related diseases[J]. Trends Biochem Sci, 2020, 45(7):578-592.
|
9 |
Huang W, Hickson LJ, Eirin A, et al. Cellular senescence: the good, the bad and the unknown[J]. Nat Rev Nephrol, 2022, 18(10):611-627.
|
10 |
Di Micco R, Krizhanovsky V, Baker D, et al. Cellular senescence in ageing: from mechanisms to therapeutic opportunities[J]. Nat Rev Mol Cell Biol, 2021, 22(2):75-95.
|
11 |
Cuollo L, Antonangeli F, Santoni A, et al. The senescence-associated secretory phenotype (SASP) in the challenging future of cancer therapy and age-related diseases[J]. Biology (Basel), 2020, 9(12):485.
|
12 |
Ohtani N. The roles and mechanisms of senescence-associated secretory phenotype (SASP): can it be controlled by senolysis?[J]. Inflamm Regen, 2022, 42(1):11.
|
13 |
Birch J, Gil J. Senescence and the SASP: many therapeutic avenues[J]. Genes Dev, 2020, 34(23-24):1565-1576.
|
14 |
Kaur J, Farr JN. Cellular senescence in age-related disorders[J]. Transl Res, 2020, 226:96-104.
|
15 |
Geng Q, Gao H, Yang R, et al. Pyrroloquinoline quinone prevents estrogen deficiency-induced osteoporosis by inhibiting oxidative stress and osteocyte senescence[J]. Int J Biol Sci, 2019, 15(1):58-68.
|
16 |
Khosla S, Farr JN, Tchkonia T, et al. The role of cellular senescence in ageing and endocrine disease[J]. Nat Rev Endocrinol, 2020, 16(5):263-275.
|
17 |
Bonello-Palot N, Simoncini S, Robert S, et al. Prelamin A accumulation in endothelial cells induces premature senescence and functional impairment[J]. Atherosclerosis, 2014, 237(1):45-52.
|
18 |
Alique M, Ruíz-Torres MP, Bodega G, et al. Microvesicles from the plasma of elderly subjects and from senescent endothelial cells promote vascular calcification[J]. Aging (Albany NY), 2017, 9(3):778-789.
|
19 |
Schafer MJ, White TA, Iijima K, et al. Cellular senescence mediates fibrotic pulmonary disease[J]. Nat Commun, 2017, 8:14532.
|
20 |
Bhat R, Crowe EP, Bitto A, et al. Astrocyte senescence as a component of Alzheimer′s disease[J]. PLoS One, 2012, 7(9):e45069.
|
21 |
An Y, Li Y, Hou Y, et al. Alzheimer′s amyloid-β accelerates cell senescence and suppresses the SIRT1/NRF2 pathway in human microglial cells[J]. Oxid Med Cell Longev, 2022:3086010.
|
22 |
Salvadori M, Rosso G, Bertoni E. Update on ischemia-reperfusion injury in kidney transplantation: pathogenesis and treatment[J]. World J Transplant, 2015, 5(2):52-67.
|
23 |
Boonstra J, Post JA. Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells[J]. Gene, 2004, 337:1-13.
|
24 |
Zhang Y, Unnikrishnan A, Deepa SS, et al. A new role for oxidative stress in aging: the accelerated aging phenotype in Sod1-/- mice is correlated to increased cellular senescence[J]. Redox Biol, 2017, 11:30-37.
|
25 |
Hochegger K, Koppelstaetter C, Tagwerker A, et al. p21 and mTERT are novel markers for determining different ischemic time periods in renal ischemia-reperfusion injury[J]. Am J Physiol Renal Physiol, 2007, 292(2):F762-F768.
|
26 |
Kailong L, Du X, Yani H, et al. P53-Rb signaling pathway is involved in tubular cell senescence in renal ischemia/reperfusion injury[J]. Biocell, 2007, 31(2):213-223.
|
27 |
Braun H, Schmidt BM, Raiss M, et al. Cellular senescence limits regenerative capacity and allograft survival[J]. J Am Soc Nephrol, 2012, 23(9):1467-1473.
|
28 |
Melk A, Schmidt BM, Vongwiwatana A, et al. Increased expression of senescence-associated cell cycle inhibitor p16INK4a in deteriorating renal transplants and diseased native kidney[J]. Am J Transplant, 2005, 5(6):1375-1382.
|
29 |
Lim WH, Clayton P, Wong G, et al. Outcomes of kidney transplantation from older living donors[J]. Transplantation, 2013, 95(1):106-113.
|
30 |
Tasaki M, Saito K, Nakagawa Y, et al. Effect of donor-recipient age difference on long-term graft survival in living kidney transplantation[J]. Int Urol Nephrol, 2014, 46(7):1441-1446.
|
31 |
Bonventre JV, Yang L. Cellular pathophysiology of ischemic acute kidney injury[J]. J Clin Invest, 2011, 121(11):4210-4221.
|
32 |
Coppé JP, Desprez PY, Krtolica A, et al. The senescence-associated secretory phenotype: the dark side of tumor suppression[J]. Annu Rev Pathol, 2010, 5:99-118.
|
33 |
Koppelstaetter C, Schratzberger G, Perco P, et al. Markers of cellular senescence in zero hour biopsies predict outcome in renal transplantation[J]. Aging Cell, 2008, 7(4):491-497.
|
34 |
Melk A, Schmidt BM, Braun H, et al. Effects of donor age and cell senescence on kidney allograft survival[J]. Am J Transplant, 2009, 9(1):114-123.
|
35 |
McGlynn LM, Stevenson K, Lamb K, et al. Cellular senescence in pretransplant renal biopsies predicts postoperative organ function[J]. Aging Cell, 2009, 8(1):45-51.
|
36 |
Childs BG, Durik M, Baker DJ, et al. Cellular senescence in aging and age-related disease: from mechanisms to therapy[J]. Nat Med, 2015, 21(12):1424-1435.
|
37 |
Martínez-Zamudio RI, Dewald HK, Vasilopoulos T, et al. Senescence-associated β-galactosidase reveals the abundance of senescent CD8+ T cells in aging humans[J]. Aging Cell, 2021, 20(5):e13344.
|
38 |
Hoffmann U, Neudörfl C, Daemen K, et al. NK cells of kidney transplant recipients display an activated phenotype that is influenced by immunosuppression and pathological staging[J]. PLoS One, 2015, 10(7):e0132484.
|
39 |
Pellegrini S, Piemonti L, Sordi V. Pluripotent stem cell replacement approaches to treat type 1 diabetes[J]. Curr Opin Pharmacol, 2018, 43:20-26.
|
40 |
姚豫桐,赖春友,冯天航,等. 同种异体胰岛联合自体外周血干细胞移植治疗1型糖尿病:随访3年的临床研究[J]. 中国普外基础与临床杂志,2022, 29(9): 1189-1194.
|
41 |
Mahmoud M, Abu-Shahba N, Azmy O, et al. Impact of diabetes mellitus on human mesenchymal stromal cell biology and functionality: implications for autologous transplantation[J]. Stem Cell Rev Rep, 2019, 15(2):194-217.
|
42 |
Oh J, Lee YD, Wagers AJ. Stem cell aging: mechanisms, regulators and therapeutic opportunities[J]. Nat Med, 2014, 20(8):870-880.
|
43 |
Turinetto V, Vitale E, Giachino C. Senescence in human mesenchymal stem cells: functional changes and implications in stem cell-based therapy[J]. Int J Mol Sci, 2016, 17(7):1164.
|
44 |
Mitchell JR, Verweij M, Brand K, et al. Short-term dietary restriction and fasting precondition against ischemia reperfusion injury in mice[J]. Aging Cell, 2010, 9(1):40-53.
|
45 |
Elseweidy MM, El-Swefy SE, Shaheen MA, et al. Effect of resveratrol and mesenchymal stem cell monotherapy and combined treatment in management of osteoporosis in ovariectomized rats: role of SIRT1/FOXO3a and Wnt/β-catenin pathways[J]. Arch Biochem Biophys, 2021, 703:108856.
|
46 |
Ould-Brahim F, Sarma SN, Syal C, et al. Metformin preconditioning of human induced pluripotent stem cell-derived neural stem cells promotes their engraftment and improves post-stroke regeneration and recovery[J]. Stem Cells Dev, 2018, 27(16):1085-1096.
|
47 |
Li ZH, Wang YL, Wang HJ, et al. Rapamycin-preactivated autophagy enhances survival and differentiation of mesenchymal stem cells after transplantation into infarcted myocardium[J]. Stem Cell Rev Rep, 2020, 16(2):344-356.
|
48 |
Martel J, Ojcius DM, Wu CY, et al. Emerging use of senolytics and senomorphics against aging and chronic diseases[J]. Med Res Rev, 2020, 40(6):2114-2131.
|
49 |
Chang J, Wang Y, Shao L, et al. Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice[J]. Nat Med, 2016, 22(1):78-83.
|
50 |
Hickson LJ, Langhi Prata LGP, Bobart SA, et al. Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease[J]. EBioMedicine, 2019, 47:446-456.
|
51 |
Megyesi J, Andrade L, Vieira JM Jr, et al. Positive effect of the induction of p21WAF1/CIP1 on the course of ischemic acute renal failure[J]. Kidney Int, 2001, 60(6):2164-2172.
|
52 |
Nishioka S, Nakano D, Kitada K, et al. The cyclin-dependent kinase inhibitor p21 is essential for the beneficial effects of renal ischemic preconditioning on renal ischemia/reperfusion injury in mice[J]. Kidney Int, 2014, 85(4):871-879.
|